Awadhesh Kumar Sharma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Awadhesh Kumar Sharma has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Santosh Kumar Sinha
Department of Cardiology, LPS Institute of Cardiology, G.S.V.M. Medical College, Kanpur, Uttar Pradesh, India
7 shared publications Ramesh Thakur
Department of Cardiology, LPS Institute of Cardiology, Kanpur, India
6 shared publicationsUmeshwar Pandey
5 shared publicationsVinay Krishna
5 shared publications- Puneet Aggarwal
Department of Cardiology, Atal Bihari Vajpayee Institute of Medical Sciences (ABVIMS) and Dr. Ram Manohar Lohia Hospital, New Delhi, India
4 shared publications C.M. Verma
3 shared publications
Latest Publications
- Open Access
- 24 March 2026
- Published by Elsevier in International Journal of Cardiology Cardiovascular Risk and Prevention
- Vol. 29, 200624
Prognostic significance of carotid intima-media thickness in patients with coronary slow flow: A systematic review and meta-analysis
- 24 March 2026
- Published by Elsevier in International Journal of Cardiology Cardiovascular Risk and Prevention
- Vol. 29, 200624
Open AccessPrognostic significance of carotid intima-media thickness in patients with coronary slow flow: A systematic review and meta-analysis
- 28 November 2024
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 77 (2) , 741-748
Audiological Profile in Patients of Chronic Stable Angina with Hearing Loss
Cardiovascular disease can affect cochlear blood flow and hearing, yet research on hearing loss in chronic stable angina patients is limited. This study aimed to investigate the relationship between hearing loss and chronic stable angina and establish association between the type and extent of hearing loss with the severity and duration of chronic stable angina. A cross-sectional study was conducted at GSVM Medical College, Kanpur, U.P. for a duration of 12 months, to examine the relationship between chronic stable angina and hearing loss. The study involved 150 patients aged 35–55 years, predominantly men with a mean age of 50 years. Participants underwent otoscopic examination and pure-tone audiometry to assess hearing. Using the NYHA criteria, patients were classified based on the severity of angina. Statistical analysis was performed with chi-square tests to identify association. 14% of patients (n=21) had bilateral hearing loss, ranging from mild to moderately severe, while 6% (n=10) had unilateral hearing loss, predominantly affecting the right ear. Notably, 80% (n=119) had normal hearing sensitivity in both ears. The hearing loss observed was sensorineural type characterized by low frequency loss. Additionally, the duration of chronic stable angina influenced hearing thresholds and hearing loss was not related to drug therapy for chronic stable angina. These findings highlight the association between chronic stable angina and hearing loss, underscoring the importance of early detection and prevention. Integrating audiologists into cardiovascular care teams could be beneficial for managing audiological concerns in patients with cardiovascular disease.
- 28 November 2024
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 77 (2) , 741-748
Audiological Profile in Patients of Chronic Stable Angina with Hearing Loss
Cardiovascular disease can affect cochlear blood flow and hearing, yet research on hearing loss in chronic stable angina patients is limited. This study aimed to investigate the relationship between hearing loss and chronic stable angina and establish association between the type and extent of hearing loss with the severity and duration of chronic stable angina. A cross-sectional study was conducted at GSVM Medical College, Kanpur, U.P. for a duration of 12 months, to examine the relationship between chronic stable angina and hearing loss. The study involved 150 patients aged 35–55 years, predominantly men with a mean age of 50 years. Participants underwent otoscopic examination and pure-tone audiometry to assess hearing. Using the NYHA criteria, patients were classified based on the severity of angina. Statistical analysis was performed with chi-square tests to identify association. 14% of patients (n=21) had bilateral hearing loss, ranging from mild to moderately severe, while 6% (n=10) had unilateral hearing loss, predominantly affecting the right ear. Notably, 80% (n=119) had normal hearing sensitivity in both ears. The hearing loss observed was sensorineural type characterized by low frequency loss. Additionally, the duration of chronic stable angina influenced hearing thresholds and hearing loss was not related to drug therapy for chronic stable angina. These findings highlight the association between chronic stable angina and hearing loss, underscoring the importance of early detection and prevention. Integrating audiologists into cardiovascular care teams could be beneficial for managing audiological concerns in patients with cardiovascular disease.
- Open Access
- 13 August 2022
- Published by Springer Nature in The Egyptian Heart Journal
- Vol. 74 (1) , 1-11
Transcatheter closure of secundum atrial septal defect using Cocoon septal occluder: immediate and long-term results
Background: Atrial septal defect (ASD) is one of the common congenital heart defects. Its management has transformed dramatically in the last 4 decades with the transition from surgical to percutaneous transcatheter closure for most secundum-type ASDs. Various devices are available for transcatheter closure of ASD with Amplatzer atrial septal occluder being most commonly used worldwide. Cocoon septal occlude has a nanocoating of platinum using nano-fusion technology over nitinol framework that imparts better radiopacity and excellent biocompatibility and prevents leaching of nickel into circulation, and by smoothening nitinol wire makes this device very soft and smooth. The aim of this study was to evaluate feasibility, effectiveness, safety, and long-term outcome of transcatheter closure of ASD using Cocoon septal occluder (Vascular Innovation, Thailand). Results: All patients undergoing transcatheter closure of hemodynamically significant ASD between September 2012 and July 2019 in our institute were included into this single-center, prospective study. Exclusion criteria were defect > 40 mm, unsuitable anatomy, Eisenmenger syndrome, and anomalous pulmonary venous return. Three hundred and twenty patients underwent device closure, of which 238 (74%) were female. The mean age was 14.6 years (range 6–29), and the median weight was 30.2 kg (range 10–53 kg). Procedure was performed under fluoroscopy using transthoracic and transesophageal echocardiography in 298 (93.1%) and 22(6.9%) patients, respectively. Balloon-assisted technique was used, when septal defect was ≥ 34 mm, in 9 (2.8%) patients. The mean diameter of defect and device was 21.4 mm (range 12–36 mm) and 26.9 mm (range 14–40 mm), respectively. Aortic rim was absent in 11 (3.4%) patients. Primary success was achieved in 312 (97.5%) patients. Early embolization to right ventricle was noted in 2 (0.6%) patients. In both cases, 40-mm device was attempted for defect of 36 mm with inadequate aortic rim using balloon-assisted technique. One (0.3%) patient developed perforation of right atrium. All were surgically repaired. Three (0.9%) patients developed complete heart block following device deployment requiring device retrieval. Two patients had had moderate residual shunt at 6 months of follow-up. After mean follow-up of 50.92 months (range 12.5–89 months), no erosion, allergic reactions to nickel, or other major complications were reported. Conclusions: Percutaneous transcatheter closure of ASD by Cocoon septal occluder (up to 36 mm) is safe and feasible with high success rate and without any significant device-related major complications over long-term follow-up. With unique device design and excellent long-term safety, it could be preferred dual-disk occluder for transcatheter closure of atrial septal defect. In most of the patients, ASD device can be safely deployed under transthoracic echocardiographic guidance.
- 13 August 2022
- Published by Springer Nature in The Egyptian Heart Journal
- Vol. 74 (1) , 1-11
Open AccessTranscatheter closure of secundum atrial septal defect using Cocoon septal occluder: immediate and long-term results
Background: Atrial septal defect (ASD) is one of the common congenital heart defects. Its management has transformed dramatically in the last 4 decades with the transition from surgical to percutaneous transcatheter closure for most secundum-type ASDs. Various devices are available for transcatheter closure of ASD with Amplatzer atrial septal occluder being most commonly used worldwide. Cocoon septal occlude has a nanocoating of platinum using nano-fusion technology over nitinol framework that imparts better radiopacity and excellent biocompatibility and prevents leaching of nickel into circulation, and by smoothening nitinol wire makes this device very soft and smooth. The aim of this study was to evaluate feasibility, effectiveness, safety, and long-term outcome of transcatheter closure of ASD using Cocoon septal occluder (Vascular Innovation, Thailand). Results: All patients undergoing transcatheter closure of hemodynamically significant ASD between September 2012 and July 2019 in our institute were included into this single-center, prospective study. Exclusion criteria were defect > 40 mm, unsuitable anatomy, Eisenmenger syndrome, and anomalous pulmonary venous return. Three hundred and twenty patients underwent device closure, of which 238 (74%) were female. The mean age was 14.6 years (range 6–29), and the median weight was 30.2 kg (range 10–53 kg). Procedure was performed under fluoroscopy using transthoracic and transesophageal echocardiography in 298 (93.1%) and 22(6.9%) patients, respectively. Balloon-assisted technique was used, when septal defect was ≥ 34 mm, in 9 (2.8%) patients. The mean diameter of defect and device was 21.4 mm (range 12–36 mm) and 26.9 mm (range 14–40 mm), respectively. Aortic rim was absent in 11 (3.4%) patients. Primary success was achieved in 312 (97.5%) patients. Early embolization to right ventricle was noted in 2 (0.6%) patients. In both cases, 40-mm device was attempted for defect of 36 mm with inadequate aortic rim using balloon-assisted technique. One (0.3%) patient developed perforation of right atrium. All were surgically repaired. Three (0.9%) patients developed complete heart block following device deployment requiring device retrieval. Two patients had had moderate residual shunt at 6 months of follow-up. After mean follow-up of 50.92 months (range 12.5–89 months), no erosion, allergic reactions to nickel, or other major complications were reported. Conclusions: Percutaneous transcatheter closure of ASD by Cocoon septal occluder (up to 36 mm) is safe and feasible with high success rate and without any significant device-related major complications over long-term follow-up. With unique device design and excellent long-term safety, it could be preferred dual-disk occluder for transcatheter closure of atrial septal defect. In most of the patients, ASD device can be safely deployed under transthoracic echocardiographic guidance.
- Open Access
- 25 April 2022
- Published by Springer Nature in The Egyptian Heart Journal
- Vol. 74 (1) , 1-6
Unguided temporary pacing via jugular/subclavian vein in an emergency department of a high-volume tertiary care hospital of India: its safety, efficacy, and practicability
Background: Temporary pacing is usually performed by cardiologists under fluoroscopic, echocardiographic, or ECG guidance. However, in the developing world, there are inadequate number of cardiologists, and C-arm, catheterization laboratories, or echocardiography are not available at primary or secondary healthcare facilities. In addition, in emergencies option of fluoroscopy and echocardiography is limited. So these patients are transferred to a facility where cardiologists and these facilities are available. Crucial time is lost in transit, which leads to increased mortality. In this study, we aimed to evaluate the safety, efficacy, and practicability of unguided temporary pacemaker insertion. Results: A total of 1093 patients were enrolled in this study. After cannulating the internal jugular vein or subclavian vein, the pacing lead attached to the pulse generator was advanced blindly till ventricular pacing was achieved. Procedural success was taken as the primary endpoint. Secondary endpoints included the number of attempts taken for successful central venous puncture and procedural time. Complications and mortality were assessed for safety outcomes. Finally, the position of the pacing lead was assessed after the procedure on X-ray or fluoroscopy. The procedure was successful in all but one patient in whom a femoral vein approach was required because of brachiocephalic vein obstruction. Right internal jugular access was achieved in 981 (89.75%) patients. The mean number of attempts taken for achieving successful venous accesses was 1.54 ± 0.85; however, in 726 (66.42%) patients it was achieved in the first attempt. The mean procedural time was 11.5 ± 2.1 min. Overall, 117 (10.70%) patients developed complications; however, most of them were minor. Pneumothorax developed in 12 (1.1%) patients, of whom 2 needed an intercostal tube. Pericardial effusion was seen in 21 (1.92%) patients. Pacing lead tip was located in the right ventricular cavity abutting interventricular septum or free wall in 843 (77.20%) patients. No mortality attributable to procedure occurred. Conclusions: Unguided temporary pacing via jugular or subclavian venous approach in an emergency setting is possible with high success and a low complication rate. Thus, it is a safe and effective procedure, and clinicians working at primary and secondary healthcare levels should be encouraged to perform this procedure. Trial registration UMIN Clinical Trials Registry, UMIN000046771. Registered 28 January 2022—Retrospectively registered, https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053348
- 25 April 2022
- Published by Springer Nature in The Egyptian Heart Journal
- Vol. 74 (1) , 1-6
Open AccessUnguided temporary pacing via jugular/subclavian vein in an emergency department of a high-volume tertiary care hospital of India: its safety, efficacy, and practicability
Background: Temporary pacing is usually performed by cardiologists under fluoroscopic, echocardiographic, or ECG guidance. However, in the developing world, there are inadequate number of cardiologists, and C-arm, catheterization laboratories, or echocardiography are not available at primary or secondary healthcare facilities. In addition, in emergencies option of fluoroscopy and echocardiography is limited. So these patients are transferred to a facility where cardiologists and these facilities are available. Crucial time is lost in transit, which leads to increased mortality. In this study, we aimed to evaluate the safety, efficacy, and practicability of unguided temporary pacemaker insertion. Results: A total of 1093 patients were enrolled in this study. After cannulating the internal jugular vein or subclavian vein, the pacing lead attached to the pulse generator was advanced blindly till ventricular pacing was achieved. Procedural success was taken as the primary endpoint. Secondary endpoints included the number of attempts taken for successful central venous puncture and procedural time. Complications and mortality were assessed for safety outcomes. Finally, the position of the pacing lead was assessed after the procedure on X-ray or fluoroscopy. The procedure was successful in all but one patient in whom a femoral vein approach was required because of brachiocephalic vein obstruction. Right internal jugular access was achieved in 981 (89.75%) patients. The mean number of attempts taken for achieving successful venous accesses was 1.54 ± 0.85; however, in 726 (66.42%) patients it was achieved in the first attempt. The mean procedural time was 11.5 ± 2.1 min. Overall, 117 (10.70%) patients developed complications; however, most of them were minor. Pneumothorax developed in 12 (1.1%) patients, of whom 2 needed an intercostal tube. Pericardial effusion was seen in 21 (1.92%) patients. Pacing lead tip was located in the right ventricular cavity abutting interventricular septum or free wall in 843 (77.20%) patients. No mortality attributable to procedure occurred. Conclusions: Unguided temporary pacing via jugular or subclavian venous approach in an emergency setting is possible with high success and a low complication rate. Thus, it is a safe and effective procedure, and clinicians working at primary and secondary healthcare levels should be encouraged to perform this procedure. Trial registration UMIN Clinical Trials Registry, UMIN000046771. Registered 28 January 2022—Retrospectively registered, https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053348
- Open Access
- 19 February 2022
- Published by Springer Nature in Cureus
- Vol. 14 (2) , e22395
Assessment of the Left Atrial Reservoir Function and Left Atrial Volume After Percutaneous Balloon Mitral Valvuloplasty Using Peak Atrial Longitudinal Strain
To evaluate the impact of successful percutaneous balloon mitral valvuloplasty (BMV) on left atrial (LA) reservoir function and LA volume in patients with severe mitral stenosis (MS) using peak atrial longitudinal strain (PALS). This was a prospective, non-randomized observational study conducted at the Laxmipat Singhania (LPS) Institute of Cardiology, Kanpur from August 2018 to February 2020 among patients with severe rheumatic MS undergoing BMV to assess LA reservoir function and its volume after BMV using PALS. Inclusion criteria were symptomatic severe rheumatic MS (NYHA ≥II), normal ventricular systolic function, and suitable valve morphology. Exclusion criteria were the coexistence of aortic valve involvement, left atrial appendage clot, mitral leak more than mild, pregnancy, hypertension, diabetes, and coronary artery disease. To assess LA reservoir function and its volume after BMV, PALS was used. LA was divided into six regions of interest and longitudinal strain curves of individual segments together with global strain were recorded. PALS was calculated at baseline 24 hours following the intervention, and at three months of follow-up. Successful BMV was performed in 260 patients (109 or 41.9% males and 151 or 58.1% females), resulting in significant improvement in mitral valve area (MVA) (0.89±0.11 cm2 vs. 1.83±0.3 cm2; p2 vs 48.4±12.5 ml/m2; p=0.003), and at three months of follow-up (56.8±14.3 ml/m2 vs. 45.4±13.3 ml/m2; p=0.002). Those with AF had lesser improvement in PALS in comparison to those with NSR (60% vs. 84%; p=0.044) at three months of follow-up. At three months, the increase in PALS was also lower in patients with a history of stroke as compared to those without it (55% vs 80%; p=0.039). Both LA volume and indexed LA volume reduced significantly immediately at 24 hours and during follow-up. LA reservoir function, as assessed by PALS, is reduced in patients with severe MS. It improved significantly within 24 hours following BMV and continued to improve at three months of follow-up. It is an underutilized modality among patients of MS for decision-making prior to intervention and to assess the effect of the intervention.
- 19 February 2022
- Published by Springer Nature in Cureus
- Vol. 14 (2) , e22395
Open AccessAssessment of the Left Atrial Reservoir Function and Left Atrial Volume After Percutaneous Balloon Mitral Valvuloplasty Using Peak Atrial Longitudinal Strain
To evaluate the impact of successful percutaneous balloon mitral valvuloplasty (BMV) on left atrial (LA) reservoir function and LA volume in patients with severe mitral stenosis (MS) using peak atrial longitudinal strain (PALS). This was a prospective, non-randomized observational study conducted at the Laxmipat Singhania (LPS) Institute of Cardiology, Kanpur from August 2018 to February 2020 among patients with severe rheumatic MS undergoing BMV to assess LA reservoir function and its volume after BMV using PALS. Inclusion criteria were symptomatic severe rheumatic MS (NYHA ≥II), normal ventricular systolic function, and suitable valve morphology. Exclusion criteria were the coexistence of aortic valve involvement, left atrial appendage clot, mitral leak more than mild, pregnancy, hypertension, diabetes, and coronary artery disease. To assess LA reservoir function and its volume after BMV, PALS was used. LA was divided into six regions of interest and longitudinal strain curves of individual segments together with global strain were recorded. PALS was calculated at baseline 24 hours following the intervention, and at three months of follow-up. Successful BMV was performed in 260 patients (109 or 41.9% males and 151 or 58.1% females), resulting in significant improvement in mitral valve area (MVA) (0.89±0.11 cm2 vs. 1.83±0.3 cm2; p2 vs 48.4±12.5 ml/m2; p=0.003), and at three months of follow-up (56.8±14.3 ml/m2 vs. 45.4±13.3 ml/m2; p=0.002). Those with AF had lesser improvement in PALS in comparison to those with NSR (60% vs. 84%; p=0.044) at three months of follow-up. At three months, the increase in PALS was also lower in patients with a history of stroke as compared to those without it (55% vs 80%; p=0.039). Both LA volume and indexed LA volume reduced significantly immediately at 24 hours and during follow-up. LA reservoir function, as assessed by PALS, is reduced in patients with severe MS. It improved significantly within 24 hours following BMV and continued to improve at three months of follow-up. It is an underutilized modality among patients of MS for decision-making prior to intervention and to assess the effect of the intervention.
- Open Access
- 1 September 2021
- Published by Elsevier in Indian Heart Journal
- Vol. 73 (5) , 617-621
An echocardiographic evaluation to determine the immediate and short-term changes in biventricular systolic and diastolic functions after PDA device closure-an observational analytical prospective study (echo- PDA study)
- 1 September 2021
- Published by Elsevier in Indian Heart Journal
- Vol. 73 (5) , 617-621
Open AccessAn echocardiographic evaluation to determine the immediate and short-term changes in biventricular systolic and diastolic functions after PDA device closure-an observational analytical prospective study (echo- PDA study)
- Open Access
- 6 July 2021
- Published by Elsevier in Indian Heart Journal
- Vol. 73 (4) , 470-475
To determine the correlation between echocardiographic diastolic parameters and invasively measured left ventricular end diastolic pressure in patients with heart failure with preserved ejection fraction- an observational, descriptive study. (CEAL-HFpEF study)
- 6 July 2021
- Published by Elsevier in Indian Heart Journal
- Vol. 73 (4) , 470-475
Open AccessTo determine the correlation between echocardiographic diastolic parameters and invasively measured left ventricular end diastolic pressure in patients with heart failure with preserved ejection fraction- an observational, descriptive study. (CEAL-HFpEF study)
- Open Access
- 1 September 2020
- Published by Elsevier in Indian Heart Journal
- Vol. 72 (5) , 435-441
A comparative assessment of Dorsal radial artery access versus classical radial artery access for percutaneous coronary angiography-a randomized control trial (DORA trial)
- 1 September 2020
- Published by Elsevier in Indian Heart Journal
- Vol. 72 (5) , 435-441
Open AccessA comparative assessment of Dorsal radial artery access versus classical radial artery access for percutaneous coronary angiography-a randomized control trial (DORA trial)
- Open Access
- 25 May 2020
- Published by Mansa STM Publishers in Indian Journal of Case Reports
- Vol. 06 (05) , 258-260
A CASE OF PERMANENT PACEMAKER IMPLANTATION FROM THE LEFT SIDE IN PERSISTENT LEFT SUPERIOR VENA CAVA – TECHNICAL CHALLENGES IN A RARE PRESENTATION
Abnormalities of the systemic venous system are not uncommon. Two well-known systemic venous anomalies are the persistent left superior vena cava (PLSVC) and interrupted inferior vena cava. PLSVC is usually detected and comes as a surprise for the cardiologist during cardiac permanent pacemaker implantation. We report the case of a 65-year-old male who had a history of recurrent syncope and diagnosed with a complete heart block 8 months back. For which, a single-chamber VVIR pacemaker was implanted through the right subclavian vein at Delhi. The patient was a known case of diabetes mellitus and had poorly controlled blood sugar levels. At present, the patient presented to our center with pacemaker pocket site infection and it was first decided to explain the right-sided permanent pacemaker, insert temporary pacemaker, and implant the new pacemaker on the left side through the left subclavian vein. In this case, during procedure, PLSVC detected accidentally; so, we discuss the challenges we faced during the right ventricular lead placement through PLSVC.
- 25 May 2020
- Published by Mansa STM Publishers in Indian Journal of Case Reports
- Vol. 06 (05) , 258-260
Open AccessA CASE OF PERMANENT PACEMAKER IMPLANTATION FROM THE LEFT SIDE IN PERSISTENT LEFT SUPERIOR VENA CAVA – TECHNICAL CHALLENGES IN A RARE PRESENTATION
Abnormalities of the systemic venous system are not uncommon. Two well-known systemic venous anomalies are the persistent left superior vena cava (PLSVC) and interrupted inferior vena cava. PLSVC is usually detected and comes as a surprise for the cardiologist during cardiac permanent pacemaker implantation. We report the case of a 65-year-old male who had a history of recurrent syncope and diagnosed with a complete heart block 8 months back. For which, a single-chamber VVIR pacemaker was implanted through the right subclavian vein at Delhi. The patient was a known case of diabetes mellitus and had poorly controlled blood sugar levels. At present, the patient presented to our center with pacemaker pocket site infection and it was first decided to explain the right-sided permanent pacemaker, insert temporary pacemaker, and implant the new pacemaker on the left side through the left subclavian vein. In this case, during procedure, PLSVC detected accidentally; so, we discuss the challenges we faced during the right ventricular lead placement through PLSVC.
- 27 April 2020
- Published by Medip Academy in International Journal of Research in Medical Sciences
- Vol. 8 (5) , 1957
Corona virus pandemic: current scenario and future hopes
Whenever we human beings challenge the existence of the god or tried to prove ourselves superior to the nature. The Nature bounces back in the form of these pandemics of infectious disease which forced us to either surrender or to lockdown ourselves in homes. The current outbreak of Corona Virus Disease-19 (COVID-19) is the same warning from nature. It is spreading very fast from one country to other and almost affects the whole world. We have many unanswered questions. Currently in absence of any definitive treatment, prevention is an only option. But future hopes are still there. This article gives a brief and accurate detail of COVID-19 pandemic regarding current situation and future hopes.
- 27 April 2020
- Published by Medip Academy in International Journal of Research in Medical Sciences
- Vol. 8 (5) , 1957
Corona virus pandemic: current scenario and future hopes
Whenever we human beings challenge the existence of the god or tried to prove ourselves superior to the nature. The Nature bounces back in the form of these pandemics of infectious disease which forced us to either surrender or to lockdown ourselves in homes. The current outbreak of Corona Virus Disease-19 (COVID-19) is the same warning from nature. It is spreading very fast from one country to other and almost affects the whole world. We have many unanswered questions. Currently in absence of any definitive treatment, prevention is an only option. But future hopes are still there. This article gives a brief and accurate detail of COVID-19 pandemic regarding current situation and future hopes.